Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding

Annals of Thoracic Surgery

Volumn 62, Issue 5, 1996, Pages 1431-1441

  Helm, Robert E ^a,b   Klemperer, John D ^a   Rosengart, Todd K ^a   Gold, Jeffrey P ^a   Peterson, Powers ^a   DeBois, William ^a   Altorki, Nasser K ^a   Lang, Samuel ^a   Thomas, Stephen ^a   Isom, O Wayne ^a   Krieger, Karl H ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEMATOCRIT; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 10544222425     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00755-2     Document Type: Article

References (25)

1. 1. Dodrill FD, Marshall N, Nyboer J, et al. The use of the heart-lung apparatus in human cardiac surgery. J Thorac Surg 1957;33:60-73.
2. 2. Lemmer JH. Reporting the results of blood conservation studies: the need for uniform and comprehensive methods. Ann Thorac Surg 1994;58:1305-6.
3. 3. Rosengart TK, Helm R, Klemperer JD, et al. Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses. Ann Thorac Surg 1994;58: 1397-403.
4. 4. Cosgrove DM, Loop BW, Lytle BW, et al. Determinants of blood utilization during myocardial revascularization. 1985; 40:380-4.
5. 5. Ochsner JL, Mills NL, Leonard GL, et al. Fresh autologous blood transfusions with extracorporeal circulation. Ann Surg 1973;177:811-7.
6. 6. Newman MF, Leone BJ, White WD, et al. The effect of hemoglobin on cerebral oxygen delivery during hypothermic cardiopulmonary bypass and rewarming [Abstract]. Circulation 1993;88(Suppl 1):246.
7. 7. Kawata H, Shimizaki Y, Miyomoto H, et al. Limits of hemodilution in total bloodless hypothermic cardiopulmonary bypass [Abstract]. Circulation 1994;90(Suppl 1):48.
8. 8. Helm RE, Klemperer JD, Rosengart T, et al. Intraoperative autologous donation: volume dependent red cell preservation. Surg Forum 1994;45:249-52.
9. 9. Albert SN. Blood volume and extracellular fluid volumes. Springfield, IL: Charles C. Thomas, 1971:281-2.
10. 10. Simon TL, Bechera FA, Murphy W. Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac Surg 1984;37:359-64.
11. 11. Ereth MH, Oliver WC, Beynan FMK, et al. Autologous platelet-rich plasma does not reduce transfusion of homologous blood products in patients undergoing repeat valvular surgery. Anesthesiology 1993;79:540-7.
12. 12. Tobe CE, Vocelka C, Sepulvada R, et al. Infusion of autologous platelet rich plasma does not reduce blood loss and blood product use after coronary artery bypass. J Thorac Cardiovasc Surg 1993;105:1007-14.
13. 13. Hirayama T, Yamaguchi H, Allers H, Roberts D. Evaluation of red cell damage during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1985;19:263-5.
14. 14. Salama A, Hugo F, Heinrich D, et al. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. N Engl J Med 1988; 318:408-14.
15. 15. Walker RH, ed. American Association of Blood Banks technical manual. 11th ed. Bethesda, MD: American Association of Blood Banks, 1993:66.
16. 16. Wildman FK, ed. Standards for blood banks and transfusion services. 15th ed. Bethesda, MD: American Association of Blood Banks, 1993.
17. 17. Moroff G, Holme S. Concepts about current conditions for the preparation and storage of platelets. Transfus Med Rev 1991;5:48-59.
18. 18. Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985;11:281-92.
19. 19. Van Oeveren W, Harder MP, Roozendaal KJ, et al. Aprotinin protects platelets against the initial effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
20. 20. Murkin JM, Lux J, Shannon NA, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994;107:554-61.
21. 21. Horrow JC. Management of the coagulopathy of CPB. In: Gravlee GP, Davis RF, Utley JR, eds. Cardiopulmonary bypass: principles and practice. Philadelphia: Williams and Wilkins, 1993:456.
22. 22. Swafford MWG, Yawn D, Wenker O, et al. Effect of adding fresh frozen plasma to the cardiopulmonary bypass machine on blood component requirements in complex CV procedures [Abstract]. Anesth Analg 1995;80:A128.
23. 23. Martinowitz U, Goor DA, Ramot B, et al. Is transfusion of fresh plasma after cardiac operations indicated? J Thorac Cardiovasc Surg 1990;100:92-8.
24. 24. Shinfeld A, Zippel D, Lavee J, et al. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrates. Ann Thorac Surg 1995;59:872-6.
25. 25. Kaplan JA, Cannarella C, Jones EL, et al. Autologous blood transfusion during cardiac surgery. A re-evaluation of three methods. J Thorac Cardiovasc Surg 1977;74:4-10.